" /> Cyclophosphamide/Docetaxel/Trastuzumab Regimen - CISMeF





Preferred Label : Cyclophosphamide/Docetaxel/Trastuzumab Regimen;

NCIt synonyms : Docetaxel/Cyclophosphamide Trastuzumab; Docetaxel Cyclophosphamide Trastuzumab; Docetaxel/Cyclophosphamide Plus Trastuzumab; Docetaxel-Cyclophosphamide-Trastuzumab Regimen; Docetaxel-Cyclophosphamide-Trastuzumab; Docetaxel/Cyclophosphamide/Trastuzumab Regimen;

NCIt related terms : TCH (Docetaxel, Cyclophosphamide); TC-H (Docetaxel) (trastuzumab-pkrb); TC-H (Docetaxel) (trastuzumab-herw); TCH (Docetaxel) (trastuzumab-pkrb); TCH (Docetaxel) (trastuzumab-anns); TCH (Docetaxel) (trastuzumab-dttb); TCH (Docetaxel) (trastuzumab-zerc); TC-H (Docetaxel) (trastuzumab-anns); TCH (Docetaxel) (trastuzumab-dkst); TC-H (Docetaxel); TCH (Docetaxel) (trastuzumab-qyyp); TC-H (Docetaxel) (trastuzumab-zerc); TC-H (Docetaxel) (trastuzumab-qyyp); TC-H (Docetaxel) (trastuzumab-dkst); TC-H (Docetaxel) (trastuzumab-dttb); TCH (Docetaxel) (trastuzumab-herw); TC-H (Docetaxel) (trastuzumab-strf); TCyH (Docetaxel) (trastuzumab-strf); TCyH (Docetaxel) (trastuzumab-qyyp);

NCIt definition : A regimen consisting of docetaxel, cyclophosphamide and trastuzumab that can be used in the treatment of breast cancer.;

NCIt note : Source: NCCN Guidelines 2017;

NCI Metathesaurus CUI : CL525011;

Codes from synonyms : 9488; 129446; 129349; 136305; 136304; 136307; 136306; 136309; 136308; 128961; 128864; 129252; 136310; 129155; 129058; 136311; 144399; 141447; 144400;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.